Entry Detail



General Information

Database ID:exR0763117
RNA Name:RPL13A
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):49487554End Site(bp):49492308
External Links:ENSG00000142541



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC068580.4
chr11
1734821
1763954
-
AGAP3
chr7
151085831
151144436
+
ABHD17B
chr9
71862452
71910931
-
AC120057.2
chr17
7240427
7244635
-
ADAM28
chr8
24294069
24359014
+
AC124312.1
chr15
24955034
25000276
+
AKT2
chr19
40230317
40285536
-
ADD3
chr10
109996368
110135565
+
ABL2
chr1
179099330
179229684
-
ACTB
chr7
5527148
5563784
-
AHCY
chr20
34280268
34311802
-
AGBL5
chr2
27042364
27070622
+
AC092143.1
chr16
89919165
89936092
+
AKR7A2
chr1
19303965
19312146
-
AC010422.3
chr19
12643831
12648397
-
AL049779.1
chr14
67659820
67690367
-
AFG3L2
chr18
12328944
12377227
-
AC015813.2
chr17
57989038
58007246
-
AIF1L
chr9
131096476
131123152
+
ACBD5
chr10
27195214
27242130
-
AC004922.1
chr7
99325879
99394653
+
AKT3
chr1
243488233
243851079
-
AC005258.1
chr19
2269525
2341172
+
AKAP8L
chr19
15380050
15419141
-
ALDOA
chr16
30064164
30070457
+
AJUBA
chr14
22971177
22982551
-
ACTR3
chr2
113890063
113962596
+
ADPGK
chr15
72751369
72785846
-
AL049629.2
chr11
33698261
33722467
-
ACKR3
chr2
236567787
236582354
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-92a-3p
chrX
134169544
134169565
-
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-7704
chr2
176188843
176188861
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004918.1
chr7
141652381
141656810
-
AC007773.1
chr19
32390050
32405560
-
AC007952.4
chr17
19112000
19112636
-
AC009022.1
chr16
69976297
70065948
-
AC010168.2
chr12
14762504
14767931
-
AC011447.3
chr19
20122569
20321305
-
AC020663.1
chr16
4730115
4752565
-
AC021078.1
chr5
149494314
149504670
-
AC023509.1
chr12
53441741
53467528
+
AC051619.7
chr15
45200325
45200632
-
AC067852.2
chr17
42552436
42554748
-
AC068473.5
chr18
79677287
79679358
-
AC104461.1
chr1
200333193
200478669
+
AC105036.3
chr15
75527150
75601205
-
AC132217.1
chr11
2129121
2129964
-
AC139149.1
chr17
81514047
81527776
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.